Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes
Not Applicable
- Conditions
- Type 1 Diabetes
- Registration Number
- NCT01840358
- Lead Sponsor
- St. Justine's Hospital
- Brief Summary
The purpose of this study is to determine if patients have more hypoglycemic episodes the first 3 days following pump start compared to their usual number of hypoglycemias with our actual pump initiation protocol.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patients with type 1 diabetes with follow-up at the CHU Sainte-Justine
- Patient about to start insulin pump therapy at the CHU Sainte-Justine
- Last HbA1c between 7.2 and 9.7%
- Informed and signed consent
Exclusion Criteria
- Type 1 diabetes diagnosed less than 1 year ago WITH total daily dose of insulin < 0.5U/kg/day
- Home of the patient at more than 50km of the CHU Sainte-Justine
- Refusal to consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Frequency of hypoglycemias 6 days Frequency of hypoglycemias defined as blood sugars \< 4.0mmol/l
- Secondary Outcome Measures
Name Time Method Frequency of hyperglycemias 6 days Frequency of hyperglycemias defined as blood sugars \> 17.0mmol/L
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms contribute to hypoglycemia risk in pediatric type 1 diabetes pump initiation?
How does insulin pump therapy compare to multiple daily injections in managing hypoglycemia in children with type 1 diabetes?
Are there specific biomarkers that identify children at higher risk for hypoglycemia during pump initiation?
What adverse events are commonly associated with insulin pump therapy in pediatric type 1 diabetes populations?
What combination therapies or alternative devices are being explored to reduce hypoglycemia in type 1 diabetes management?
Trial Locations
- Locations (1)
CHU Sainte-Justine
🇨🇦Montreal, Quebec, Canada
CHU Sainte-Justine🇨🇦Montreal, Quebec, CanadaPatricia Olivier, MDPrincipal Investigator